BRMS1 and breast cancer: BRMS1 has been first described in 2000 following the observation thatentering a typical, neomycin-tagged human chromosome 11 decreased metastatic potential ofthe MDA-MB435 human breast cancer cells by 70- 90% with no prevention of primary tumorgrowth (11).